![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
Phase II results of olaparib and abiraterone for mCRPC (ecancer) View |
![]() |
PROfound: Olaparib for HRR+ mCRPC (OncLive) View |
![]() |
ASCO 2018: Latest Developments in Non-Metastatic u0026 Metastatic Castration-Resistant Prostate Cancer (ecancer) View |
![]() |
Olaparib and Keytruda For Advanced Prostate Cancer | | Learn About Clinical Trials (Prostate Cancer Research Institute) View |
![]() |
PARP Inhibitors in Advanced Prostate Cancers (OncLive) View |
![]() |
Anti-Androgen Trials (Grand Rounds in Urology) View |
![]() |
TALAPRO-1: phase II study of talazoparib in patients with DNA damage repair alterations and mCRPC (ecancer) View |
![]() |
PROfound: PARP inhibitor olaparib compared with new hormonal agents in advanced castration resis... (ecancer) View |
![]() |
Expert report on survival data from pivotal trials with PARP inhibitors for BRCA-mut. Ovarian Cancer (European Society for Medical Oncology (ESMO)) View |
![]() |
Maintenance therapy with PARP inhibitor olaparib delays progression in patients with BRCA-relate... (ecancer) View |